Ivan Jarry - Biotech Acquisition Chief Officer
BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Insider
Ivan Jarry is Chief Officer of Biotech Acquisition Co
Age | 45 |
Phone | 212 227 1905 |
Biotech Acquisition Management Efficiency
Biotech Acquisition's management efficiency ratios could be used to measure how well Biotech Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.Biotech Acquisition Co currently holds 153.35 K in liabilities with Debt to Equity (D/E) ratio of 3.48, implying the company greatly relies on financing operations through barrowing. Biotech Acquisition has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biotech Acquisition's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Noah Webster | Integral Ad Science | 51 | |
Roee Ivgy | BOS Better Online | N/A | |
Moshe Zeltzer | BOS Better Online | 44 | |
David Herman | Boston Omaha Corp | 40 | |
Louis Martin | United Natural Foods | 54 | |
Gloria Boyland | United Natural Foods | N/A | |
Steven McGhie | Boston Omaha Corp | 58 | |
John Clare | United Natural Foods | 53 | |
Bradford Briner | Boston Omaha Corp | 43 | |
Michael CPA | John B Sanfilippo | 49 | |
Brendan Keating | Boston Omaha Corp | 38 | |
William Krueger | The Andersons | 58 | |
Robert Janecek | Integral Ad Science | N/A | |
Shayn Wallace | John B Sanfilippo | 52 | |
Niall Hogan | Integral Ad Science | N/A | |
Thomas Joseph | Integral Ad Science | N/A | |
Vishnu Srinivasan | Boston Omaha Corp | 41 | |
Jeffrey Royal | Boston Omaha Corp | 44 | |
Mark Bushway | United Natural Foods | N/A | |
Helene Monat | Integral Ad Science | N/A | |
R Esper | United Natural Foods | N/A |
Management Performance
Return On Asset | -0.0085 |
Biotech Acquisition Leadership Team
Elected by the shareholders, the Biotech Acquisition's board of directors comprises two types of representatives: Biotech Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotech. The board's role is to monitor Biotech Acquisition's management team and ensure that shareholders' interests are well served. Biotech Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotech Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Shleifer, Chairman CEO | ||
Ivan Jarry, Chief Officer | ||
Albert MBA, Chief Director | ||
Thomas Fratacci, CFO Treasurer |
Biotech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotech Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.0085 | |||
Current Valuation | 290.09 M | |||
Shares Outstanding | 23 M | |||
Shares Owned By Institutions | 100.00 % | |||
Number Of Shares Shorted | 9.3 K | |||
Price To Earning | 29.21 X | |||
Price To Book | 1.33 X | |||
EBITDA | (6.86 M) | |||
Net Income | (6.86 M) | |||
Cash And Equivalents | 1.7 K |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |